Veritable’s Stryker SYK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-16,291
| Closed | -$4.97M | – | 709 |
|
|
2023
Q2 | $4.97M | Sell |
16,291
-263
| -2% | -$76K | 0.08% | 123 |
|
|
2023
Q1 | $4.73M | Buy |
16,554
+6
| +0% | +$1.59K | 0.08% | 127 |
|
|
2022
Q4 | $4.05M | Buy |
16,548
+4,232
| +34% | +$960K | 0.07% | 145 |
|
|
2022
Q3 | $2.49M | Sell |
12,316
-2,517
| -17% | -$529K | 0.05% | 182 |
|
|
2022
Q2 | $2.95M | Sell |
14,833
-544
| -4% | -$128K | 0.05% | 172 |
|
|
2022
Q1 | $4.11M | Buy |
15,377
+234
| +2% | +$60.6K | 0.06% | 153 |
|
|
2021
Q4 | $4.05M | Sell |
15,143
-417
| -3% | -$109K | 0.06% | 163 |
|
|
2021
Q3 | $4.1M | Buy |
15,560
+88
| +0.6% | +$23.5K | 0.07% | 149 |
|
|
2021
Q2 | $4.02M | Buy |
15,472
+125
| +0.8% | +$32K | 0.06% | 153 |
|
|
2021
Q1 | $3.74M | Buy |
15,347
+836
| +6% | +$200K | 0.06% | 151 |
|
|
2020
Q4 | $3.56M | Sell |
14,511
-103
| -0.7% | -$23.3K | 0.07% | 140 |
|
|
2020
Q3 | $3.04M | Buy |
14,614
+1,341
| +10% | +$261K | 0.06% | 149 |
|
|
2020
Q2 | $2.39M | Sell |
13,273
-886
| -6% | -$163K | 0.05% | 164 |
|
|
2020
Q1 | $2.36M | Sell |
14,159
-1,046
| -7% | -$204K | 0.06% | 164 |
|
|
2019
Q4 | $3.19M | Buy |
15,205
+266
| +2% | +$55.2K | 0.06% | 171 |
|
|
2019
Q3 | $3.23M | Sell |
14,939
-270
| -2% | -$57.9K | 0.06% | 159 |
|
|
2019
Q2 | $3.13M | Sell |
15,209
-472
| -3% | -$90.1K | 0.06% | 161 |
|
|
2019
Q1 | $3.1M | Sell |
15,681
-145
| -0.9% | -$26.1K | 0.06% | 164 |
|
|
2018
Q4 | $2.48M | Sell |
15,826
-238
| -1% | -$39.8K | 0.06% | 174 |
|
|
2018
Q3 | $2.85M | Sell |
16,064
-1,379
| -8% | -$235K | 0.06% | 169 |
|
|
2018
Q2 | $2.94M | Buy |
17,443
+3,119
| +22% | +$525K | 0.06% | 163 |
|
|
2018
Q1 | $2.31M | Sell |
14,324
-118
| -0.8% | -$19K | 0.05% | 190 |
|
|
2017
Q4 | $2.24M | Sell |
14,442
-1,068
| -7% | -$163K | 0.04% | 197 |
|
|
2017
Q3 | $2.2M | Sell |
15,510
-1,035
| -6% | -$148K | 0.05% | 207 |
|
|
2017
Q2 | $2.3M | Sell |
16,545
-1,986
| -11% | -$273K | 0.05% | 199 |
|
|
2017
Q1 | $2.44M | Buy |
18,531
+34
| +0.2% | +$4.29K | 0.06% | 184 |
|
|
2016
Q4 | $2.22M | Buy |
18,497
+579
| +3% | +$66.6K | 0.05% | 189 |
|
|
2016
Q3 | $2.09M | Buy |
17,918
+557
| +3% | +$64.9K | 0.05% | 200 |
|
|
2016
Q2 | $2.08M | Buy |
17,361
+1,174
| +7% | +$131K | 0.05% | 190 |
|
|
2016
Q1 | $1.74M | Buy |
16,187
+462
| +3% | +$45.5K | 0.05% | 211 |
|
|
2015
Q4 | $1.46M | Sell |
15,725
-75
| -0.5% | -$7.18K | 0.04% | 238 |
|
|
2015
Q3 | $1.49M | Buy |
15,800
+296
| +2% | +$29.3K | 0.04% | 221 |
|
|
2015
Q2 | $1.48M | Sell |
15,504
-1,204
| -7% | -$114K | 0.04% | 232 |
|
|
2015
Q1 | $1.54M | Sell |
16,708
-54
| -0.3% | -$5.03K | 0.03% | 306 |
|
|
2014
Q4 | $1.58M | Sell |
16,762
-498
| -3% | -$44.2K | 0.03% | 299 |
|
|
2014
Q3 | $1.39M | Sell |
17,260
-1,220
| -7% | -$100K | 0.03% | 324 |
|
|
2014
Q2 | $1.56M | Sell |
18,480
-1,323
| -7% | -$108K | 0.03% | 308 |
|
|
2014
Q1 | $1.61M | Buy |
19,803
+116
| +0.6% | +$9.23K | 0.04% | 290 |
|
|
2013
Q4 | $1.48M | Sell |
19,687
-73
| -0.4% | -$5.33K | 0.03% | 304 |
|
|
2013
Q3 | $1.34M | Sell |
19,760
-776
| -4% | -$53.6K | 0.03% | 324 |
|
|
2013
Q2 | $1.33M | Buy |
+20,536
| New | +$1.36M | 0.03% | 322 |
|
Other funds holding SYK
GT
Veritable's SYK Position: Q3 2023 in Review
Veritable sold out of Stryker (SYK) in Q3 2023, closing a stake of 16,291 shares — an estimated $4.97M sold.
Veritable first reported a position in SYK in Q2 2013 and held it in 41 quarters. The position peaked at $4.97M in Q2 2023. 1,771 funds tracked by Wall St. Rank hold SYK as of Q3 2023.
- Veritable reported no remaining Stryker position as of Q3 2023 after selling out during the quarter.
- Veritable sold 16,291 Stryker shares in Q3 2023, an estimated $4.97M.
- Veritable first reported a position in Stryker in Q2 2013 and held it in 41 quarters.
- Veritable's Stryker position peaked at $4.97M in Q2 2023.
- 1,771 funds tracked by Wall St. Rank held Stryker as of Q3 2023.
Based on Veritable's 13F filing for Q3 2023.